The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study
Background Whether angiotensin receptor-neprilysin inhibitor (ARNI) can reduce the incidence of cardiovascular events and improve peritoneal function in peritoneal dialysis (PD) patients remains unclear. Thus, this study aims to clarify the role of ARNI in PD patients.Methods This was a multicenter...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2024-12-01
|
| Collection: | Renal Failure |
| Sujets: | |
| Accès en ligne: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2431637 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
